 |
| |
| Sep-18-17 02:14PM | Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q1, 2018 By the Numbers : September 18, 2017 Capital Cube +5.28% |
| 09:15AM | Champions Oncology announces publication highlighting clinical correlation between patient-derived xenograft (PDX) model responses and patient responses to oncology therapies PR Newswire |
| Sep-14-17 04:30PM | Champions Oncology Reports Record Quarterly Revenue of $5 Million PR Newswire -5.29% |
| Sep-07-17 05:00PM | Champions Oncology to Announce First Quarter Financial Results on Thursday, September 14, 2017 PR Newswire |
| Aug-21-17 08:30AM | Champions Oncology Announces Strategic Collaboration with AstraZeneca to Develop Unique Cohorts of Patient-Derived Xenograft (PDX) Models PR Newswire +6.27% |
| Aug-18-17 08:30AM | Champions Oncology Announces Research Collaboration with The Addario Lung Cancer Medical Institute to Develop Unique Cohort of Patient-Derived Xenograft (PDX) Models PR Newswire |
| Aug-15-17 04:57AM | The Addario Lung Cancer Medical Institute, Champions Oncology and Motivated Patients Announce a Research Collaboration and Launch of a Patient Driven Clinical Study in ROS1 Positive Cancer PR Newswire |
| Aug-04-17 07:20AM | Corporate News Blog - Theravance Biopharmas Velusetrag Successful in Mid-Stage Gastroparesis Study ACCESSWIRE |
| Aug-01-17 10:07AM | Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q4, 2017 By the Numbers : August 1, 2017 Capital Cube +10.92% |
| Jul-27-17 04:01PM | Champions Oncology Reports 38% Revenue Growth for Fiscal Year Ended April 30, 2017 PR Newswire |
| Jul-17-17 08:30AM | Champions Oncology Schedules Fourth Quarter and Fiscal Year 2017 Earnings Call PR Newswire |
| Mar-23-17 01:04PM | CHAMPIONS ONCOLOGY, INC. Financials +6.04% |
| Mar-22-17 10:10AM | Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q3, 2017 By the Numbers : March 22, 2017 Capital Cube |
| 10:10AM | Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q3, 2017 By the Numbers : March 22, 2017 |
| Mar-17-17 01:56PM | CHAMPIONS ONCOLOGY, INC. Files SEC form 10-Q, Quarterly Report |
| Mar-16-17 04:03PM | CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and |
| 04:01PM | Champions Oncology Reports 40% Revenue Growth PR Newswire |
| 09:00AM | Champions Oncology Announces Plan to Open New Lab Facility in Rockville, Maryland PR Newswire |
| 07:07AM | Q3 2017 Champions Oncology Inc Earnings Release - After Market Close |
| Mar-07-17 08:00AM | Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 16, 2017 PR Newswire |
| Feb-16-17 09:36AM | Champions Oncology Announces New Collection of Patient-Derived Xenograft (PDX) Models Available for Translational Research PR Newswire |
| Jan-26-17 01:29PM | CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Change in Directors or Principal Officers |
| Jan-19-17 10:38AM | Champions Oncology Retains Hayden IR to Execute Comprehensive Investor Relations Program PR Newswire +7.56% |
| Dec-16-16 08:34AM | Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q2, 2017 By the Numbers : December 16, 2016 Capital Cube |
| 08:34AM | Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q2, 2017 By the Numbers : December 16, 2016 |
| Dec-14-16 04:08PM | CHAMPIONS ONCOLOGY, INC. Files SEC form 10-Q, Quarterly Report -7.08% |
| 06:53AM | How Champions Oncology Inc (CSBR) Stacks Up Against Its Peers Insider Monkey |
| 06:53AM | How Champions Oncology Inc (CSBR) Stacks Up Against Its Peers at Insider Monkey |
| Nov-29-16 04:16PM | CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Pr |
| 04:15PM | Champions Oncology Reports 50% Revenue Growth, Accelerated Progress on Path to Profitability and Future Role Changes of the Senior Leadership PR Newswire |
| 07:07AM | Q2 2017 Champions Oncology Inc Earnings Release - After Market Close |
| Nov-23-16 10:20AM | Champions Oncology to Announce Second Quarter Financial Results on Tuesday, November 29, 2016 PR Newswire |
| Nov-17-16 04:05PM | Champions Oncology Signs $2 million Contract PR Newswire |
| Nov-16-16 07:05PM | Champions Oncology Inc (CSBR) Stock: Have We Met? at Insider Monkey -8.47% |
| Nov-15-16 02:27PM | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Delaware Law by Certain Officers and Directors of Champions Oncology, Inc. Business Wire |
| Nov-01-16 12:06PM | CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Change in Directors or Principal Officers |
| Oct-25-16 08:59AM | Insider Selling at Dominos Pizza Inc. (DPZ) and Intel Corporation (INTC), Plus Insider Buying at Three Other Companies at Insider Monkey |
| Oct-14-16 01:12PM | CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders |
| Oct-12-16 06:56AM | Notable Insider Selling at Applied Materials Inc. (AMAT) and Costco Wholesale (COST), Plus Insider Moves at 3 Other Companies at Insider Monkey |
| Sep-14-16 03:09PM | CHAMPIONS ONCOLOGY, INC. Files SEC form 10-Q, Quarterly Report |
| Sep-13-16 09:54AM | Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q1, 2017 By the Numbers : September 13, 2016 |
| Sep-09-16 08:16AM | CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and |
| 08:15AM | Champions Oncology Beats Revenue Guidance for Quarter; Reaffirms Full Year Guidance of 43 - 60% Revenue Growth PR Newswire |
| 07:07AM | Q1 2017 Champions Oncology Inc Earnings Release - Before Market Open |
| Sep-06-16 08:30AM | Champions Oncology to Announce First Quarter Financial Results on Friday, September 9, 2016 PR Newswire |
| Jul-29-16 01:11PM | CHAMPIONS ONCOLOGY, INC. Files SEC form 10-K, Annual Report |
| Jul-28-16 08:00AM | Champions Oncology Announces Revenue Up 26%, Projects 43% - 60% Growth For Current Fiscal Year PR Newswire |
| 07:53AM | CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and |
| 07:07AM | Q4 2016 Champions Oncology Inc Earnings Release - Before Market Open |
| Jul-25-16 06:18PM | Champions Oncology to Announce Year-End 2016 Financial Results on Thursday, July 28, 2016 PR Newswire |
| Jul-22-16 04:10PM | CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi |
| Jul-18-16 08:30AM | Champions Oncology Successfully Delivers First AML Study PR Newswire |
| Jun-15-16 04:33PM | CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Stat |
| 12:00PM | Champions Oncology, Inc. Announces Closing of Public Offering of Common Stock PR Newswire |
| Jun-09-16 07:30PM | Champions Oncology, Inc. Announces Pricing of Public Offering of Common Stock PR Newswire |
| May-23-16 11:07AM | Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q3, 2016 By the Numbers : May 23, 2016 |
| May-18-16 05:15PM | CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits |
| Apr-13-16 04:01PM | CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial State |
| Apr-12-16 12:30PM | Champions Oncology Announces Addition to Board of Directors PR Newswire -5.75% |
| Mar-25-16 03:02PM | CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or St |
| Mar-22-16 11:06AM | Champions Oncology, Inc. :CSBR-US: Earnings Analysis: Q3, 2016 By the Numbers |
| Mar-16-16 10:03AM | CHAMPIONS ONCOLOGY, INC. Files SEC form 10-Q, Quarterly Report |
| Mar-15-16 08:31AM | CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and |
| 08:30AM | Champions Oncology Reports Results for the Third Quarter Ended January 31, 2016 PR Newswire |
| 07:07AM | Q3 2016 Champions Oncology Inc Earnings Release - Before Market Open |
| Mar-11-16 09:00AM | Champions To Present at the 28th Annual ROTH Capital Conference on March 16, 2016 PR Newswire -7.16% |
| Mar-10-16 10:00AM | Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 15, 2016 PR Newswire |
| Mar-07-16 05:15PM | CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -6.89% |
| Jan-21-16 11:00AM | Champions Oncology Announces Initiation of Prospective Correlative Trial in Sarcoma PR Newswire |
| Dec-24-15 11:02AM | Champions Oncology, Inc. Earnings Analysis: Q2, 2016 By the Numbers |
| Dec-15-15 05:23PM | CHAMPIONS ONCOLOGY, INC. Files SEC form 10-Q, Quarterly Report +7.62% |
| Dec-14-15 04:50PM | Champions Oncology Reports Results for the Second Quarter Ended October 31, 2015 PR Newswire -5.97% |
| 04:35PM | CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and |
| 04:01PM | Champions Oncology Leading Paradigm Shift to Incorporation of PDX Models into Clinical Trial Strategy PR Newswire |
| 07:07AM | Q2 2016 Champions Oncology Inc Earnings Release - After Market Close |
| Dec-10-15 10:45AM | Champions Oncology to Announce Second Quarter Financial Results on Monday, December 14, 2015 PR Newswire |
| Nov-30-15 11:51AM | Champions Oncology to Present at LD MICRO Investor Conference PR Newswire |
| Oct-29-15 04:02PM | CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or St |
| Oct-16-15 12:11PM | Champions Oncology, Inc.: A look at fundamentals : October 16, 2015 |
| Oct-15-15 08:01AM | CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders |
| Sep-23-15 10:56AM | Champions Oncology, Inc. Earnings Q1, 2015 -9.09% |
| Sep-11-15 04:05PM | CHAMPIONS ONCOLOGY, INC. Files SEC form 10-Q, Quarterly Report |
| Sep-10-15 04:05PM | Champions Oncology Reports Results for the First Quarter Ended July 31, 2015 PR Newswire |
| 04:02PM | CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and |
| 07:07AM | Q1 2015 Champions Oncology Inc Earnings Release - After Market Close |
| Sep-08-15 10:30AM | Champions Oncology to Announce First Quarter Financial Results on Thursday, September 10, 2015 PR Newswire |
| Sep-05-15 09:15AM | 5 Top Biotech Stocks That Ran This Past Week at 24/7 Wall St. |
| Aug-31-15 05:26PM | CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Change in Directors or Principal Officers |
| 10:00AM | Champions Oncology, Inc. (Nasdaq: CSBR) to Ring The Nasdaq Stock Market Closing Bell GlobeNewswire |
| Aug-21-15 10:18AM | CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits |
| 09:38AM | Champions Oncology Announces Uplisting to NASDAQ PR Newswire |
| Aug-17-15 09:11AM | Champions Oncology Files Patents for Use of PDX Platform in Immune-Oncology PR Newswire +8.33% |
| Aug-13-15 06:03AM | CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other E |
| Aug-12-15 09:25AM | /C O R R E C T I O N -- Champions Oncology, Inc./ PR Newswire |
| Aug-05-15 02:00PM | Champion Oncology Announces Additions to Leadership Team to Support Continued Growth PR Newswire |
| Jul-29-15 04:12PM | CHAMPIONS ONCOLOGY, INC. Files SEC form 10-K, Annual Report -16.35% |
| Jul-28-15 08:31AM | CHAMPIONS ONCOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and +13.02% |
|
|
|
|
| Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized Oncology Solutions (POS) that assist physicians in developing personalized treatment options for cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. The company also offers POS products, including personalized tumor boards that are designed to provide access to oncologists with expertise in particular tumor types; and provides access to gene sequencing that analyzes the genetic makeup of patient's tumor for the purpose of identifying potentially useful drugs. In addition, it offers Translational Oncology Solutions (TOS), including a preclinical Tumorgraft platform to pharmaceutical and biotechnology companies that use vivo studies, which rely on implanting multiple tumors from TumorBank in mice and testing the therapy of interest on tumors. The company markets its products through Internet, word of mouth, and a network of sales force to patients and physicians. Champions Oncology, Inc. has collaboration agreements with The Addario Lung Cancer Medical Institute and AstraZeneca to develop cohorts of PDX models. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011 to reflect its new focus on developing technologies to personalize the development and use of oncology drugs. Champions Oncology, Inc. is headquartered in Hackensack, New Jersey. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| Morris Ronnie | President | Oct 21 | Buy | 1.66 | 30,000 | 49,900 | 1,111,347 | Oct 24 02:05 PM | | Morris Ronnie | President | Oct 19 | Buy | 1.70 | 10,000 | 17,000 | 1,081,347 | Oct 20 04:35 PM | | ACKERMAN JOEL | Chief Executive Officer | Oct 18 | Buy | 1.70 | 2,000 | 3,393 | 1,044,266 | Oct 20 11:13 AM | | Morris Ronnie | President | Oct 14 | Buy | 1.66 | 10,305 | 17,106 | 1,071,347 | Oct 17 09:54 AM | | ACKERMAN JOEL | Chief Executive Officer | Oct 14 | Buy | 1.66 | 1,300 | 2,153 | 1,042,266 | Oct 14 04:40 PM | | ACKERMAN JOEL | Chief Executive Officer | Oct 13 | Buy | 1.68 | 6,000 | 10,052 | 1,040,966 | Oct 14 04:40 PM | | Morris Ronnie | President | Oct 13 | Buy | 1.67 | 29,695 | 49,494 | 1,061,042 | Oct 14 01:09 PM | | Morris Ronnie | President | Oct 10 | Buy | 1.66 | 9,537 | 15,831 | 1,031,347 | Oct 11 10:38 AM | | ACKERMAN JOEL | Chief Executive Officer | Oct 07 | Buy | 1.64 | 5,000 | 8,200 | 1,034,966 | Oct 07 02:18 PM | | ACKERMAN JOEL | Chief Executive Officer | Oct 06 | Buy | 1.61 | 3,202 | 5,169 | 1,029,966 | Oct 07 02:18 PM |
|
|
|
|
|
|
